Great Plains Chapter of the American College of Cardiology

Latest in Cardiology from ACC.org

• ACC, Coalition Partners Call For Passage of Federal Legislation to Tackle Prior Auth Overuse, Abuse
  The ACC joined members of the Regulatory Relief Coalition (RRC) this week to celebrate the reintroduction of the Improving Seniors’ Timely Access to Care Act. (H.R. 3514/S. 1816) By tackling the overuse and abuse of prior authorization by some Medicare Advantage (MA) plans, this legislation would safeguard patient access to quality, guideline-recommended medical care and […]
• How Do Cardiometabolic Risk Factors in Pregnancy, Early Childhood Food Insecurity Impact Future CV Health?
  Research examining how cardiometabolic risk factors in pregnant women may affect the blood pressure (BP) of their offspring and the association between early childhood food insecurity and future cardiovascular health were published May 7...
• Amiloride Noninferior to Spironolactone For Resistant Hypertension
  Amiloride is noninferior to spironolactone in lowering home-measured systolic blood pressure (SBP) among patients with resistant hypertension, according to results from a clinical trial published May 14 in JAMA.
• Timing of Antihypertensives Does Not Affect CV Risk, Survival in Primary Care or Frail Older Patients
  Taking antihypertensive medications at bedtime rather than in the morning is safe for adults with hypertension in primary care and for frail older nursing home patients, but it does not reduce cardiovascular risk or all-cause death in either group...
• Colchicine vs. Placebo in Reducing CV Events; DOACs vs. Warfarin After TAVR; CSP vs. BiVP and Echo Response
  In this week’s View, Dr. Eagle looks colchicine versus placebo in reducing major adverse cardiovascular (CV) events including CV death or myocardial infarction in patients with vascular disease.